ARENA PHARMACEUTICALS is in a rapidly changing global market, where we work with a sense of urgency every day to understand the needs of all our stakeholders, identify bold, sometimes disruptive, ideas to discover and develop medicines for patients, and relentlessly execute until it’s done.

Our GI research portfolio includes etrasimod, a once-daily, oral, selective sphingosine 1-phosphate (S1P) receptor modulator, currently in Phase 3 for ulcerative colitis and in Phase 2b for Crohn’s disease and olorinab, an oral, highly selective, peripherally acting, full agonist of the cannabinoid receptor 2 (CB2), currently in Phase 2b for IBS visceral pain.


These are investigational compounds, not approved for use in any country.


To learn more about Arena, please visit us at


ARENA – Care More. Act Differently.


Cory N. Iverson

Regional Medical Advisor (West)

Arena Pharmaceuticals

P: (858) 349-9177


Arena Pharmaceuticals Live Exhibits - SCSG 2020


8:00-9:00am 12/4/2020


12:30-1:00pm 12/4/2020



10:00-11:00am 12/5/2020


The Southern California Society of Gastroenterology (SCSG) is a non-profit professional society dedicated to enhancing the practice of gastroenterology by enriching gastroenterologists in the region through continuing medical education. 

The SCSG aims to provide an environment of professional growth and social exchange for its members


We take our privacy seriously, please click here to view our Privacy Notice.


1400 N. Harbor Blvd.
Suite 625

Fullerton, CA 92835


Registration/Membership Inquiries contact:


Sponsorship Inquiries contact:


Fax: 866.735.4373

  • Grey Facebook Icon

© 2021 Southern California Society of Gastroenterology